CHRS Average Annual Return 10 Years

Growth of $10,000.00
Without Dividends Reinvested Into CHRS

Also see:
• CHRS stock yearly return 2015
• CHRS stock yearly return 2016
• CHRS stock yearly return 2017
• CHRS stock yearly return 2018
• CHRS stock yearly return 2019
• CHRS stock yearly return 2020
• CHRS stock yearly return 2021
• CHRS stock yearly return 2022
• CHRS stock yearly return 2023
• CHRS stock yearly return 2024
• CHRS YTD return

Compare CHRS average annual return versus benchmarks:

S&P Average Annual Return
Dow Average Annual Return
Nasdaq 100 Average Annual Return
Russell 2000 Average Annual Return
Gold Average Annual Return
10 Year Treasury Average Annual Return

Start date:	01/26/2015
End date:	01/23/2025
Start price/share:	$22.14
End price/share:	$1.28
Dividends collected/share:	$0.00
Total return:	-94.22%
CHRS Average Annual Return:	-24.80%
Starting investment:	$10,000.00
Ending investment:	$578.33
Years:	10.00

CHRS average annual return is presented with the assumption of reinvestments of any dividends on ex-date.

Coherus BioSciences, Inc. is a commercial-stage biopharmaceutical company. Co. is focused on the research, development and commercialization of immunotherapies to treat cancer. Co.'s immuno-oncology pipeline includes multiple antibody immunotherapy candidates focused on enhancing the innate and adaptive immune responses to enable a robust antitumor immunologic response and enhance outcomes for patients with cancer. Casdozokitug is an IL-27 antagonistic antibody, which is being evaluated in two ongoing clinical studies: a Phase I/II study in advanced solid tumors and a Phase II study in hepatocellular carcinoma. The CHRS average annual return 10 years is shown above.

The Average Annual Return on the CHRS average annual return 10 years page and across the coverage universe of our site, is a measure of the annualized return over the past ten years (or specified start date) for a given investment (up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window to capture long-term trends.

Thus, researching Average Annual Returns is good practice for investors — whether CHRS average annual return 10 years or other benchmarks/peers — and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors by performing the CHRS average annual return calculation with any dividends reinvested as applicable (on ex-dates).

Quotes delayed 20 minutes

Free CHRS Email Alerts:
Get Dividend Alerts

Get SEC Filing Alerts

10 Most Oversold Stocks in the S&P

10 Most Overbought Stocks in the S&P

10 ETFs With Stocks That Insiders Are Buying

10 ETFs With Most Upside To Analyst Targets

The DividendRank Top 25

Warren Buffett Dividend Stocks

10 Cheap Dividend Stocks Under $10

10 Energy Stocks You Can Buy Cheaper Than Insiders Did

10 Top DividendRank'ed Energy Stocks

The 10 Highest Yielding Preferred Stocks

The 15 Most Active Call & Put Options of the S&P 500 Components

Video: Don't Forget Dividends in Average Annual Return!

If the video does not load after a few moments, Upgrade to the Latest Flash Player.

Coherus BioSciences (CHRS) is categorized under the Healthcare sector; to help you further research average annual return performance across stocks, below are some other companies in the same sector:

CI Average Annual Return
CING Average Annual Return
CKPT Average Annual Return
CLDX Average Annual Return
CLNN Average Annual Return
CLOV Average Annual Return
CLPT Average Annual Return
CLRB Average Annual Return
CLSD Average Annual Return
CLYM Average Annual Return
More Healthcare companies »

What has the average annual return been for CHRS over the past ten years?

✔️Accepted answer: The ten year CHRS average annual return has been -24.80%.

What start date was used in your CHRS average annual return calculation?

✔️Accepted answer: The start date was 01/26/2015.

What end date was used in your CHRS average annual return calculation?

✔️Accepted answer: The end date was 01/23/2025.

If I had invested $10,000 into CHRS ten years ago, how much would I have today?

✔️Accepted answer: Today, as of 01/23/2025, you would have $578.33.

What does that work out to on a total return basis?

✔️Accepted answer: The CHRS ten year total return ending 01/23/2025 works out to -94.22%.

CHRS Average Annual Return 10 Years | www.AverageAnnualReturn.com | Copyright © 2021 - 2025, All Rights Reserved